Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma. - Burcher KM; Lantz JW; Gavrila E; Abreu A; Burcher JT; Faucheux AT; Xie A; Jackson C; Song AH; Hughes RT; Lycan T Jr; Bunch PM; et al. (Cancers, 2021)